BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15338189)

  • 21. Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients.
    Soltész P; Veres K; Lakos G; Kiss E; Muszbek L; Szegedi G
    Lupus; 2003; 12(4):302-7. PubMed ID: 12729054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus.
    Taraborelli M; Leuenberger L; Lazzaroni MG; Martinazzi N; Zhang W; Franceschini F; Salmon J; Tincani A; Erkan D
    Lupus; 2016 Oct; 25(12):1365-8. PubMed ID: 26945023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus.
    Campos LM; Kiss MH; D'Amico EA; Silva CA
    Lupus; 2003; 12(11):820-6. PubMed ID: 14667097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies.
    Hachulla E; Michon-Pasturel U; Leys D; Pruvo JP; Queyrel V; Masy E; Arvieux J; Caron C; Brevet-Coupé F; Hatron PY; Devulder B
    Lupus; 1998; 7(2):124-31. PubMed ID: 9541097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiphospholipid antibodies and venous thromboembolism.
    Ginsberg JS; Wells PS; Brill-Edwards P; Donovan D; Moffatt K; Johnston M; Stevens P; Hirsh J
    Blood; 1995 Nov; 86(10):3685-91. PubMed ID: 7579334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Picceli VF; Skare TL; Nisihara RM; Nass FR; Messias-Reason IT; Utiyama SR
    Lupus; 2016 Apr; 25(4):412-7. PubMed ID: 26537423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
    Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Khamashta MA; Amengual O; Hughes GR
    J Rheumatol; 1998 Jun; 25(6):1104-8. PubMed ID: 9632071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study.
    Berube C; Mitchell L; Silverman E; David M; Saint Cyr C; Laxer R; Adams M; Vegh P; Andrew M
    Pediatr Res; 1998 Sep; 44(3):351-6. PubMed ID: 9727712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies].
    Monti M; Borgognoni F; Pastacci L; Vincentelli GM
    G Ital Cardiol (Rome); 2016 Dec; 17(12):1001-1007. PubMed ID: 28151504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
    Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
    Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population.
    Dayama A; Dass J; Mahapatra M; Saxena R
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):657-662. PubMed ID: 27067744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus.
    Wong KL; Liu HW; Ho K; Chan K; Wong R
    J Rheumatol; 1991 Aug; 18(8):1187-92. PubMed ID: 1941822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study.
    Akca ÜK; Batu ED; Kısaarslan AP; Poyrazoğlu H; Ayaz NA; Sözeri B; Sağ E; Atalay E; Demir S; Karadağ ŞG; Demir F; Bilginer Y; Gümrük F; Özen S
    Lupus; 2021 Oct; 30(12):1983-1990. PubMed ID: 34459313
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.